⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 27, 2026BiomedicinesOpen Access

Bridging the Gap in Lung Cancer: Novel Biomarkers, Metabolic Drivers, and Advanced Therapeutics from Bench to Bedside

Jeongmi Lee Seung Hyeun Lee

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to understand the role of novel biomarkers and metabolic drivers in enhancing lung cancer treatment efficacy.
Integrated translational science approaches in lung cancer therapies.
Focus on both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
Evaluated advanced therapeutic interventions and their outcomes.
Identified key biomarkers that can guide personalized treatment strategies.
Demonstrated improved efficacy of novel therapeutics over standard treatments in lung cancer.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Explores novel biomarkers and advanced therapies in lung cancer, suggesting improved precision in treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lee et al. (2026) studied this question.

synapsesocial.com/papers/6a69a2a3c8da07d9defa6433 https://doi.org/10.3390/biomedicines14081681

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Redefining the Diagnostic and Therapeutic Landscape of Non-Small Cell Lung Cancer in the Era of Precision Medicine2025
2An evolving landscape: predictive and therapeutic biomarkers in advanced non-small cell lung cancerHuman Clinical Trial · 2026
3Advancing neoadjuvant therapies in resectable non-small cell lung cancer: implications for novel treatment strategies and biomarker discovery2024 · 5 citations
4Biomarker Integration in the Perioperative Management of Early-Stage Non-Small-Cell Lung CancerOriginal Research · 2026
5Comprehensive Advances in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Precision Therapy2025

Advances in Lung Cancer Management: Novel Approaches and the Road Ahead2026
Clinical Advancement of Biomarkers for Precise Lung Cancer Therapy: Challenges and Strategies2026
Molecular Mechanisms and Potential Predictive Biomarkers in Advanced Non-small Cell Lung Cancer: A Summary of Current and Future Trends2024
A Reproducible CD36-Enriched Lipid-Associated Macrophage State in Lung Adenocarcinoma and Its Spatial Relationship to Exhausted CD8+ T CellsBiomedicines · 2026
MX1 Expression in Cancer Cells Is Strongly Linked to CD8+ T-Cell Infiltration and PD-L1 Expression: A Tissue Microarray Study Evaluating More than 14,000 Tumors from 145 Different Tumor EntitiesBiomedicines · 2026

More from Biomedicines